Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.

Lukas JoosF VetterliT JaegerA CozzioJ von KempisA Rubbert-Roth

Published in: Clinical and experimental dermatology (2021)

Dear Editor, Cutaneous manifestations of systemic lupus erythematosus (SLE) have been shown to significantly impair quality of life.1 Treatment options for patients with SLE are limited and new therapies are needed.

Keyphrases

systemic lupus erythematosus
disease activity
rheumatoid arthritis
replacement therapy